FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065674 [Registered on: 15/04/2024] Trial Registered Prospectively
Last Modified On: 09/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Theraputical clinical]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of two drugs punarnava mandoor and vatsakbeejadi churana in improving low heamoglobin level 
Scientific Title of Study   Randomized Clinical Study to compare the efficacy of Vatsak Beejadi Churanam with Punarnava Mandoor in improving Haemoglobin level in Pandu Rog Iron deficiency Anaemia  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Deepika 
Designation  MD scholar 
Affiliation  Choudhary Brahm Prakash Ayurved Charak Sansthan 
Address  Choudhary Brahm prakash Ayurveda Charak Sansthan Room no. 108 PG Department of Kayachikitsa

South West
DELHI
110073
India 
Phone  9079980429  
Fax    
Email  deepikadinod96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr NR Singh 
Designation  Head of Department 
Affiliation  Choudhary Brahma Prakash Ayurved Charak sansthan  
Address  PG Department of Kayachikitsa Choudhary Brahma Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi

South West
DELHI
110073
India 
Phone  9560659728  
Fax    
Email  naimishraj@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr NR Singh 
Designation  Head of Department 
Affiliation  Choudhary Brahma Prakash Ayurved Charak sansthan  
Address  PG Department of Kayachikitsa Choudhary Brahma Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi

South West
DELHI
110073
India 
Phone  9560659728  
Fax    
Email  naimishraj@yahoo.com  
 
Source of Monetary or Material Support  
Choudhary Brahma Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 110073 India 
 
Primary Sponsor  
Name  Ch Brahma Prakash Ayurveda Charak Santhan 
Address  Ch Brahma Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 110073 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Deepika  Choudhary Brahma Prakash Ayurved Charak Sansthan  Room No. 108 PG Department of Kayachikitsa Ch Brahma Prakash Ayurveda Charak Sansthan
South West
DELHI 
9079980429

deepikadinod96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committee Ch Brahm Prakash Ayurved Charak Sansthan CBPACS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Vatsak Beejadi Churanam , Reference: Ashtang Sangrah, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -NIL
2Comparator ArmDrugClassical(1) Medicine Name: Poonarnava Mandoor, Reference: Charak Chikitsa, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Takra), Additional Information: NIl
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients between the age group 18 and 60 years irrespective of gender caste and
religion
Patient not suffering from any severe disease other than Iron deficiency Anaemia
Haemoglobin level -between 6-10 gm/dl
Patient having score between 7 to 21 of subjective criteria
Patient willing to sign the informed consent for study
Patient who are able to take medicine orally Patient who are not registered in any other research project 
 
ExclusionCriteria 
Details  Patients suffering from any other systemic diseases
Age less than 18 years and more than 60 years
Haemoglobin level-below 6 gm/dl and more than 10 gm dl
Pregnant women and lactating mothers
Patient not willing to sign the informed consent
Patient who are not able to take medicine orally
Patient registered in any other research projects
Patient already taking any medicine for Anaemia  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improving the Haemoglobin level  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
The subjective criteria for secondary assessment include the
Pandutaa (Pallor)
Swasa (Dyspnoea)
Bhrama (Giddiness)
Pindiko-dveshtan (Calf-claudication)
Gatrashool (Bodyache)
Hrud spandanam (Palpitation)
Shram (Fatigue) 
30 days 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   20/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

INTRODUCTION: 

Pandu is a rasa pradoshaj vikar, it is due to excessive exacerbations of three doshas especially pitta afflicts dhatus as a result complexion, strength, unctuousness . Pandu is a symptom as well as a disease characterized by pallor discolouration. It mostly resembles with Anaemia of modern science.

Anaemia is a condition in which the number of red blood cells or the Haemoglobin concentration within them is lower than normal. Haemoglobin is needed to carry oxygen and if you have too few or abnormal red blood cells, or not enough Haemoglobin, there will be a decreased capacity of the blood to carry oxygen to the body’s tissues. This results in symptoms such as Fatigue, Weakness, Dizziness and Shortness of breath, among others. The most common causes of anaemia include Nutritional deficiencies, particularly Iron deficiency, though deficiencies in Folate, vitamins B12 and A are also important causes; Haemoglobinopathies; and Infectious diseases, such as Malaria, Tuberculosis, HIV and Parasitic infections.Anaemia is associated with Fatigue, Weakness, Dizziness and Drowsiness. 

The signs include loss of normal colour in the skin and also in the lips, tongue, nail beds and the blood vessels in the sclera part of the eye. Without treatment, Anaemia can worsen and become underlying causes of chronic ill health, such as impaired foetal development during pregnancy, delayed cognitive development and increased risk of infection in young children and reduced physical capacity in all people.

Low birth weight infants, young children and women of child bearing age are particularly at risk of anaemia.

Lacunae in existing knowledge & Need of Study –

There are several approaches for managing anemia to certain extent . Iron supplementation is most recommended drug in this category. The most common side effects of iron supplementation are nausea/ vomiting , constipation or dairrhea , flatulence , metallic taste, staining of teeth , or epigastric distress. Consider this the search for more ayurvedic drugs to control anemia is an alternative approach these days

 

Proposed outcome:

Correction of functional status of digestive system as well as hepatobiliary system so that it leads to better absorption of iron which we take in our daily diet.

RESEARCH QUESTION:  

Is there any difference in the efficacy of Vatsakbeejadi Churnam and Punarnava Mandoor in improving low Haemoglobin status in Pandu Rog?  

NULL HYPOTHESIS (H0) -There is no difference in effectiveness of VatsakBeejadi Churanam and Punarnava Mandoor for improving Haemoglobin deficiency status in Pandu Roga.

ALTERNATIVE HYPOTHESIS – (H1)   VatsakBeejadi Churanam is more effective than Punarnava Mandoor for improving Haemoglobin deficiency status in Pandu Roga.

(H2) Punarnava Mandoor is more effective than Vatsak Beejadi Churanam for improving Haemoglobin deficiency status in Pandu Roga.

AIM- To compare the efficacy of Vatsakbeejadi Churanam with Punarnava Mandoor for improving Haemoglobin deficiency status in Pandu Roga.

 OBJECTIVES –

PRIMARY OBJECTIVE- To compare the effectiveness of Vatsakbeejadi Churanam with poonarnava mandoor in Improving Haemoglobin level of subjects.

SECONDARY OBJECTIVE- To compare the effectiveness of Vatsakbeejadi Churanam with poonarnava mandoor in improving haemoglobin level of subject

in improving following clinical features-

Panduta (Pallor)

Swasa  (Dyspnoea)

Hrud - spandanam (Palpitation)

Gatrashool (Bodyache)

Bhrama (Giddiness)

Pindiko-dveshtan (Calf -claudication)

Shram (Fatigue)

 

 STUDY DESIGN-  

Single centred,

Open label,

Parallel arm study with comparator group

Interventional study,

Without any crossover 

STUDY SETTING- The subject will be taken from O.P.D. and I.P.D. of Ch. Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, New Delhi.

SAMPLE CLASSIFICATION: 

Group A: Punarnava Mandoor

Group B: Vatsakbeejadi Churanam

SAMPLE SIZE– 25 cases each 

 NO. OF GROUPS- Two groups

 Group A (Comparator group) -

25 patients will be randomly selected for this group and they will be treated for 45 days as under.

Punarnava Mandoor 2-tab (250mg each) BD after meal with takra for 30 days.

 Group B (Trial group) -

25 patients will be randomly selected for this group and they will be treated for 45 days as under.

5gm Vatsakbeejadi Churanam twice a day after meal with honey for 30 days.

INCLUSION CRITERIA -

Patients between the age group 18 and 60 years, irrespective of gender, caste and religion

Patient not suffering from any severe disease other than Iron deficiency Anaemia. 

Haemoglobin level -between 6-10 gm/dl  

Patient having score between 7 to 21 of subjective criteria                                                                                                         

Patient willing to sign the informed consent for study.

Patient who are able to take medicine orally. 

Patient who are not registered in any other research project

EXCLUSION CRITERIA -

Patients suffering from any other systemic diseases .

Age <18 years and more than 60 years

Haemoglobin level-below 6 gm/dl and more than 10 gm/dl

Pregnant women and lactating mothers

Patient not willing to sign the informed consent

Patient who are not able to take medicine orally

Patient registered in any other research projects

Patient already taking any medicine for Anaemia

TOTAL DURATION OF TRIAL: - 45days

DURATION OF DRUG ADMINISTRATION: -30 days

FOLLOW UP- on 45th day

DURATION OF STUDY- 18 months

PRIMARY ASSESMENT  CRITERIA:

 Improving the Haemoglobin level

 SECONDARY ASSESMENT  CRITERIA:

The subjective criteria for  secondary assessment include the

A.     Pandutaa (Pallor),

B.    Swasa (Dyspnoea),

C.    Bhrama (Giddiness)

D.    Pindiko-dveshtan (Calf-claudication)

E.    Gatrashool (Bodyache)

F.     Hrud-spandanam (Palpitation)

G     Shram (Fatigue)

EXPECTED OUTCOME OF THE STUDY

Improvement in the subjective parameters of Pandu roga ( Iron deficiency aneamia)

 

Improvement in the objective parameters of Pandu roga( Iron deficiency aneamia)

 

 

 

 
Close